openPR Logo
Press release

Oral Contraceptive Pills Market: Snapshot

02-02-2017 02:44 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost effective, and are the first line of treatment for birth control.

“Focusing on untapped market with unmet needs is one of the major growth strategies adopted by an increasing number of players in the oral contraceptive pills market,” states the author of the study. For instance, in 2014, India-based Mankind Pharma expanded its business by exporting products to Kenya, Tanzania, Ethiopia, and Uganda.

Strategic collaborations, the launch of new products, and a focus on research and development also serve as highly lucrative investment options for companies in the oral contraceptive pills market.

Read Full Report:

High Unmet Contraceptive Needs Emerging Owing to Increased Incidence of Unintended Pregnancies

One of the leading factors driving the oral contraceptive pills market is the high incidence rate of unintended pregnancies among women between the age of 15 and 44. The Centers for Disease Control and Prevention (CDC) states that in the U.S. alone, an estimated 37% of the total pregnancies in the country between 2006 and 2010 were unintended.

“The growing percentage of unintended pregnancies in several parts of the world, including among married women, has also boosted the demand for oral contraceptive pills,” states the author of the TMR report. The United Nations has reported in a study that the percentage of married women using at least one method of contraception has been steadily rising and this is a positive sign for the global contraceptives market as a whole.

The increasing maternal age, late pregnancies, and rising awareness programs by governments and NGOs to promote the usage of contraceptives are also fueling the oral contraceptive pills market.

Legal, Religious, and Ethical Hurdles in Some Countries Deter Growth

In some countries, the oral contraceptive pills market is restricted by a number of social, ethical, and religious barriers. “The Middle East is one of the key regions where the oral contraceptive pills market faces major roadblocks,” the TMR analyst states. “The sale of emergency contraceptive pills in the region is restricted owing to the fact that they are considered to be a means of abortion.”

Ineffective or strict legal and policy frameworks on reproductive rights and health in many countries also acts as a deterrent to the growth of the oral contraceptive pills market.

Download exclusive Sample of this report:

Demand for Generic Oral Contraceptive Pills Takes Precedence over Branded Pills

The value of the oral contraceptive pills market is poised to rise from US$13.1 bn in 2014 to US$22.9 bn by 2023. If these values hold true, the market is likely to expand at a steady CAGR of 6.6% during the forecast period. Combination oral contraceptive pills held the leading share in the market in 2014 and the opportunity in this segment is likely to be worth nearly US$18 bn by 2023. Combination oral contraceptive pills are also identified to form the most rapidly growing segment during the forecast period, exhibiting a 6.8% CAGR therein.

Generic oral contraceptive pills gained a higher share in the overall market in 2014 compared to branded pills and are also projected to record the highest CAGR by 2023. By region, while North America will continue leading the global oral contraceptive pills market, Asia Pacific is forecast to register the fastest growth from 2015 to 2023.

This review is based on the findings of a TMR report titled “Oral Contraceptive Pills Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015-2023.”

Key Takeaways:

Revenue of global oral contraceptive pills market to cross US$22 bn by 2023.
Combination oral contraceptive pills present the most lucrative investment option for market players.
Generic oral contraceptive pills exhibit greater demand compared to branded versions.
Legal and ethical roadblocks in the Middle East a cause for concern.
Global Oral Contraceptive Pills Market, by Types

Progestin Only
Global Oral Contraceptive Pills Market, by Category

Global Oral Contraceptive Pills Market, by Geography

North America
Rest of Europe
Asia Pacific
Rest pf APAC
Latin America
Rest of LATAM
Middle East & Africa
Saudi Arabia
Rest of MEA

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Contraceptive Pills Market: Snapshot here

News-ID: 427044 • Views: 501

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases

More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Asia-Pacific Contraceptive Drugs Market Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Sample Copy
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the